/prod01/channel_3/media/tcd/innovation/images/industry/inflazome.png)
Turning World Class Research into World Class Companies
Every year, Trinity Innovation fosters innovation and high-tech entrepreneurship across Trinity College, collaborating with University members at all stages of the commercialisation process and inviting industry contribution and engagement. This is accomplished by identifying, selecting and developing multiple potential spin-out and spin-in opportunities.
For Campus/Spinout Companies
Our goal is to support Trinity campus companies to achieve and sustain growth, providing them with the best chance for long-term survival and success. Through a transparent and efficient process, we help develop the business model, build a team, create an investor-ready business plan, identify customers, and engage with investors. Our services include:
- IP Management
- Customer & Partner networks
- Business Planning
- Market Research
- Networks & Scaling
- Access to Funding
- Building your Team
Want to progress your commercial idea?
For Industry, Investors & Entrepreneurs
We invite collaborations with industry to facilitate the creation of new opportunities and establish high-potential start-up (HPSU) companies based on Trinity IP (spin-outs) or aligned with Trinity’s research focus (spin-ins). Our Knowledge Exchange Office can guide investors and entrepreneurs on accessing our pipeline opportunities and explain how Trinity can assist with spin-out company formation and the technology transfer process.
If you are interested in investing in or leading early-stage companies, let’s arrange a call.
Join us on the Journey
Trinity College plays a hands-on role in helping translate academic research to achieve both economic and societal impact. In the last thirty years, over 100 Trinity campus companies have raised more than €200 million in seed investment; enabled the direct creation of in excess of 3,000 jobs and have delivered over €1.2 billion in exports.
Trinity’s Knowledge Exchange Office can guide investors and entrepreneurs on accessing our pipeline opportunities and explain how Trinity can assist with spin-out company formation and the technology transfer process.
See a selection of Trinity's campus companies below for more information.
Translational research startup improving the sustainability and accessibility of high performance electron microscopy.
Integrity Indicators for Intelligent Packaging for food. First product is a sensor formulation that changes colour in the presence of oxygen at different concentrations.
Using Surface Acoustic Wave (SAW) technology, this passive strain sensing solution for cutting tools can push the tools to their productive limit.
Products that apply thermal dynamics to make the thermal energy useful from electronics producing excessive heat.
CroíValve is developing a minimally invasive device to treat tricuspid regurgitation, with a solution that is quicker, easier and safer to deliver.
Simple to use iTremor device that enables quick diagnosis of Traumatic Brain Injury and Sports Concussion.
Developing the optimum wound closure device that provides superior results to meticulously performed surgical sutures at the speed and convenience of a skin stapler.
Real time 3D ablation analysis in Atrial Fibrillation allows physicians to visualise, analyse and verify ablation lesion path.
ETU’s powerful AI-driven platform helps design, develop and deliver immersive workplace simulations.
Generate AR/ VR content with videos captured with hand held consumer devices.
Offering full Application end-to-end solutions using differentiated next generation Low Power Wide Area loT
Automatically generates software for data curation, integration and publication from a rich semantic schema.
Get immediate climate guidance on business decisions or content powered by AI.
Fungal endophytes that can enhance crop growth, nutrient acquisition and improve the plant’s ability to tolerate stress (e.g.drought and pest resistance).
Novel therapeutic and 
targeted pathway for the treatment of autoimmune diseases.
Accelerating drug discovery programmes in neuropsychiatric, neurodegenerative and rare neurological disorders.
Anti-tumour immunity and development of adjuvants for therapeutic and prophylactic cancer vaccines